504 related articles for article (PubMed ID: 31445191)
21. Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Xie HX; Zhang J; Li Y; Zhang JH; Liu SK; Zhang J; Zheng H; Hao GZ; Zhu KK; Jiang CS
Bioorg Chem; 2021 Oct; 115():105236. PubMed ID: 34411978
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Sharafi Z; Faramarzi MA; Rastegar H; Nasli Esfahani E; Bandarian F; Ranjbar Rashidi P; Rahimi R; Biglar M; Mahdavi M; Larijani B
Mol Divers; 2021 May; 25(2):877-888. PubMed ID: 32189236
[TBL] [Abstract][Full Text] [Related]
23. Discovery of new 2-phenyl-1H-benzo[d]imidazole core-based potent α-glucosidase inhibitors: Synthesis, kinetic study, molecular docking, and in vivo anti-hyperglycemic evaluation.
Li Y; Zhang JH; Xie HX; Ge YX; Wang KM; Song ZL; Zhu KK; Zhang J; Jiang CS
Bioorg Chem; 2021 Dec; 117():105423. PubMed ID: 34717239
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
25. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids.
Sun H; Song X; Tao Y; Li M; Yang K; Zheng H; Jin Z; Dodd RH; Pan G; Lu K; Yu P
Future Med Chem; 2018 May; 10(9):1055-1066. PubMed ID: 29676183
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, In Vitro α-Glucosidase Inhibitory Activity and Molecular Docking Studies of Novel Benzothiazole-Triazole Derivatives.
Gong Z; Peng Y; Qiu J; Cao A; Wang G; Peng Z
Molecules; 2017 Sep; 22(9):. PubMed ID: 28914795
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, in vitro α-glucosidase inhibitory activity and docking studies of novel chromone-isatin derivatives.
Wang G; Chen M; Qiu J; Xie Z; Cao A
Bioorg Med Chem Lett; 2018 Jan; 28(2):113-116. PubMed ID: 29208524
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and α-glucosidase-inhibitory activity of phenoxy-biscoumarin-N-phenylacetamide hybrids.
Ansari S; Azizian H; Pedrood K; Yavari A; Mojtabavi S; Faramarzi MA; Golshani S; Hosseini S; Biglar M; Larijani B; Rastegar H; Hamedifar H; Mohammadi-Khanaposhtani M; Mahdavi M
Arch Pharm (Weinheim); 2021 Dec; 354(12):e2100179. PubMed ID: 34467580
[TBL] [Abstract][Full Text] [Related]
29. Tyramine Derivatives as Potent Therapeutics for Type 2 Diabetes: Synthesis and
Bashir MA; Javaid K; Shaikh M; Choudhary MI; Siddiqui H
Med Chem; 2020; 16(8):1124-1135. PubMed ID: 32003674
[TBL] [Abstract][Full Text] [Related]
30. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, biological evaluation and molecular docking study of N-arylbenzo[d]oxazol-2-amines as potential α-glucosidase inhibitors.
Wang G; Peng Z; Wang J; Li J; Li X
Bioorg Med Chem; 2016 Nov; 24(21):5374-5379. PubMed ID: 27614916
[TBL] [Abstract][Full Text] [Related]
32. Mechanistic investigation of anthocyanidin derivatives as α-glucosidase inhibitors.
Kim JH; Kim HY; Jin CH
Bioorg Chem; 2019 Jun; 87():803-809. PubMed ID: 30978605
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel 1,2,4-triazine derivatives bearing carbazole moiety as potent α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Bioorg Med Chem Lett; 2016 Jun; 26(12):2806-2809. PubMed ID: 27177827
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies.
Adib M; Peytam F; Shourgeshty R; Mohammadi-Khanaposhtani M; Jahani M; Imanparast S; Faramarzi MA; Larijani B; Moghadamnia AA; Esfahani EN; Bandarian F; Mahdavi M
Bioorg Med Chem Lett; 2019 Mar; 29(5):713-718. PubMed ID: 30661823
[TBL] [Abstract][Full Text] [Related]
35. In vitro α-Glucosidase Inhibition by Non-sugar based Triazoles of Dibenzoazepine, their Structure-Activity Relationship, and Molecular Docking.
Khan MA; Javaid K; Wadood A; Jamal A; Batool F; Fazal-Ur-Rehman S; Basha FZ; Choudhary MI
Med Chem; 2017; 13(7):698-704. PubMed ID: 28745232
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 1H-1,2,3-triazole derivatives as new α-glucosidase inhibitors and their molecular docking studies.
Avula SK; Khan A; Rehman NU; Anwar MU; Al-Abri Z; Wadood A; Riaz M; Csuk R; Al-Harrasi A
Bioorg Chem; 2018 Dec; 81():98-106. PubMed ID: 30118991
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and kinetics studies of N'-(2-(3,5-disubstituted-4H-1,2,4-triazol-4-yl)acetyl)-6/7/8-substituted-2-oxo-2H-chromen-3-carbohydrazide derivatives as potent antidiabetic agents.
Menteşe E; Baltaş N; Bekircan O
Arch Pharm (Weinheim); 2019 Dec; 352(12):e1900227. PubMed ID: 31609028
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, in-vitro evaluation, molecular docking, and kinetic studies of pyridazine-triazole hybrid system as novel α-glucosidase inhibitors.
Moghimi S; Salarinejad S; Toolabi M; Firoozpour L; Esmaeil Sadat Ebrahimi S; Safari F; Madani-Qamsari F; Mojtabavi S; Faramarzi MA; Karima S; Pakrad R; Foroumadi A
Bioorg Chem; 2021 Apr; 109():104670. PubMed ID: 33588241
[TBL] [Abstract][Full Text] [Related]
39. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
40. New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study.
Adib M; Peytam F; Rahmanian-Jazi M; Mahernia S; Bijanzadeh HR; Jahani M; Mohammadi-Khanaposhtani M; Imanparast S; Faramarzi MA; Mahdavi M; Larijani B
Eur J Med Chem; 2018 Jul; 155():353-363. PubMed ID: 29902721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
